Smart for Life (SMFL) Competitors $0.0005 0.00 (-87.50%) As of 01:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. NAVB, OBSV, SYRS, SCPS, VRPX, STAB, EVLO, CMRA, GNCAQ, and GNCAShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Navidea Biopharmaceuticals (NAVB), ObsEva (OBSV), Syros Pharmaceuticals (SYRS), Scopus BioPharma (SCPS), Virpax Pharmaceuticals (VRPX), Statera Biopharma (STAB), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), and Genocea Biosciences (GNCA). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors Navidea Biopharmaceuticals ObsEva Syros Pharmaceuticals Scopus BioPharma Virpax Pharmaceuticals Statera Biopharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Genocea Biosciences Smart for Life (NASDAQ:SMFL) and Navidea Biopharmaceuticals (NYSE:NAVB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability. Which has stronger earnings & valuation, SMFL or NAVB? Navidea Biopharmaceuticals has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/ANavidea Biopharmaceuticals$8.13K6.16-$15.18MN/AN/A Does the media prefer SMFL or NAVB? In the previous week, Smart for Life's average media sentiment score of 0.00 beat Navidea Biopharmaceuticals' score of -0.80 indicating that Smart for Life is being referred to more favorably in the media. Company Overall Sentiment Smart for Life Neutral Navidea Biopharmaceuticals Negative Is SMFL or NAVB more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Navidea Biopharmaceuticals N/A N/A N/A Which has more volatility and risk, SMFL or NAVB? Smart for Life has a beta of 17.06, suggesting that its stock price is 1,606% more volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Do insiders & institutionals hold more shares of SMFL or NAVB? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 0.0% of Navidea Biopharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by company insiders. Comparatively, 43.7% of Navidea Biopharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummarySmart for Life beats Navidea Biopharmaceuticals on 4 of the 7 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$3.41B$5.81B$10.01BDividend YieldN/AN/A5.29%4.53%P/E RatioN/A9.4375.6926.28Price / Sales0.0077.60538.99121.33Price / CashN/A5.6237.2059.76Price / Book0.001.2011.506.41Net Income-$22.68M$17.44M$3.28B$270.56M7 Day PerformanceN/A9.57%1.30%3.01%1 Month PerformanceN/A41.81%11.25%9.74%1 Year PerformanceN/A-18.70%59.54%26.68% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00-87.5%N/A-99.6%$4K$11.11M0.00110Gap DownNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010High Trading VolumeOBSVObsEvaN/A$0.00flatN/AN/A$39KN/A0.0050SYRSSyros Pharmaceuticals3.9503 of 5 stars$0.00-50.0%$1.00+90,809.1%-99.9%$30K$386K0.00120Gap DownSCPSScopus BioPharmaN/A$0.00flatN/A+0.0%$17KN/A0.009VRPXVirpax Pharmaceuticals0.1027 of 5 stars$0.01flatN/A-99.9%$14KN/A0.007Gap DownSTABStatera BiopharmaN/A$0.00+100.0%N/A-83.3%$11KN/A0.0020Gap DownHigh Trading VolumeEVLOEvelo BiosciencesN/A$0.00flatN/AN/A$9KN/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6K$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070 Related Companies and Tools Related Companies Navidea Biopharmaceuticals Competitors ObsEva Competitors Syros Pharmaceuticals Competitors Scopus BioPharma Competitors Virpax Pharmaceuticals Competitors Statera Biopharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
